ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Also Senate, House committees request further research, reports from NCI.

September 19, 2003

NCI Director asks NCAB to pray for him.

June 18, 2004

Major Changes Being Considered By NCI For FCRA

April 14, 1978

NCI Clarifies Plan For Review Of Epidemiologic Research

June 1, 2001

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Breast Cancer Coalition Demonstrations Crucial To Obtaining Windfall

October 16, 1992